PFIZER INC Equity Securities, FV-NI, Realized Gain (Loss)
PFIZER INC (PFE) reported Equity Securities, FV-NI, Realized Gain (Loss) of $16.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-08-04
- PFIZER INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-06-28 was $16.00M, a 60.00% increase year-over-year.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-29 was $6.00M, a 99.35% decline year-over-year.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-12-31 was -$1.19B.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-09-28 was $224.00M, a 75.49% decline year-over-year.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for fiscal 2025 was -$35.00M, a 103.12% decline from fiscal 2024.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for fiscal 2024 was $1.12B, a 36.03% decline from fiscal 2023.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $1.75B, a 1292.06% increase from fiscal 2022.
- PFIZER INC equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $126.00M, a 57.50% increase from fiscal 2021.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 3 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-28 | $16.00M 10-Q · filed 2026-08-04 | $22.00M 10-Q · filed 2026-08-04 | -$1.17B derived: sum of 3 quarters · filed 2026-08-04 | -$948.00M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-29 | $6.00M 10-Q · filed 2026-05-05 | -$1.19B derived: sum of 2 quarters · filed 2026-05-05 | -$964.00M derived: sum of 3 quarters · filed 2026-05-05 | -$954.00M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | -$1.19B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$970.00M derived: sum of 2 quarters · filed 2026-02-26 | -$960.00M derived: sum of 3 quarters · filed 2026-08-04 | -$35.00M 10-K · filed 2026-02-26 | |||
| 2025-09-28 | $224.00M 10-Q · filed 2025-11-04 | $234.00M derived: sum of 2 quarters · filed 2026-08-04 | $1.16B 10-Q · filed 2025-11-04 | $1.15B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-29 | $10.00M 10-Q · filed 2026-08-04 | $934.00M 10-Q · filed 2026-08-04 | $927.00M derived: sum of 3 quarters · filed 2026-08-04 | $1.84B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-30 | $924.00M 10-Q · filed 2026-05-05 | $917.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.83B derived: sum of 3 quarters · filed 2026-05-05 | $1.83B derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $907.00M derived: sum of 2 quarters · filed 2026-02-26 | $909.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.12B 10-K · filed 2026-02-26 | |||
| 2024-09-29 | $914.00M 10-Q · filed 2025-11-04 | $916.00M derived: sum of 2 quarters · filed 2025-11-04 | $1.13B 10-Q · filed 2025-11-04 | $2.84B derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-05 | $216.00M 10-Q · filed 2025-08-05 | $1.92B derived: sum of 3 quarters · filed 2026-02-26 | $1.92B derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $214.00M 10-Q · filed 2025-05-05 | $1.92B derived: sum of 2 quarters · filed 2026-02-26 | $1.92B derived: sum of 3 quarters · filed 2026-02-26 | $1.94B derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $1.71B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.71B derived: sum of 2 quarters · filed 2026-02-26 | $1.72B derived: sum of 3 quarters · filed 2026-02-26 | $1.75B 10-K · filed 2026-02-26 | |||
| 2023-10-01 | $1.00M 10-Q · filed 2024-11-04 | $15.00M derived: sum of 2 quarters · filed 2024-11-04 | $48.00M 10-Q · filed 2024-11-04 | $90.00M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-07-02 | $14.00M 10-Q · filed 2024-08-05 | $47.00M 10-Q · filed 2024-08-05 | $89.00M derived: sum of 3 quarters · filed 2025-02-27 | $94.00M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-04-02 | $33.00M 10-Q · filed 2024-05-08 | $75.00M derived: sum of 2 quarters · filed 2025-02-27 | $80.00M derived: sum of 3 quarters · filed 2025-02-27 | $148.00M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $47.00M derived: sum of 2 quarters · filed 2025-02-27 | $115.00M derived: sum of 3 quarters · filed 2025-02-27 | $126.00M 10-K · filed 2025-02-27 | |||
| 2022-10-02 | $5.00M 10-Q · filed 2023-11-08 | $73.00M derived: sum of 2 quarters · filed 2023-11-08 | $84.00M 10-Q · filed 2023-11-08 | $81.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-07-03 | $68.00M 10-Q · filed 2023-08-09 | $79.00M 10-Q · filed 2023-08-09 | $76.00M derived: sum of 3 quarters · filed 2024-02-22 | $154.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-04-03 | $11.00M 10-Q · filed 2023-05-10 | $8.00M derived: sum of 2 quarters · filed 2024-02-22 | $86.00M derived: sum of 3 quarters · filed 2024-02-22 | $62.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $75.00M derived: sum of 2 quarters · filed 2024-02-22 | $51.00M derived: sum of 3 quarters · filed 2024-02-22 | $80.00M 10-K · filed 2024-02-22 | |||
| 2021-10-03 | $78.00M 10-Q · filed 2022-11-09 | $54.00M derived: sum of 2 quarters · filed 2022-11-09 | $83.00M 10-Q · filed 2022-11-09 | $90.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-07-04 | -$24.00M 10-Q · filed 2022-08-10 | $5.00M 10-Q · filed 2022-08-10 | $12.00M derived: sum of 3 quarters · filed 2023-02-23 | $10.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-04-04 | $28.00M 10-Q · filed 2022-05-11 | $36.00M derived: sum of 2 quarters · filed 2023-02-23 | $34.00M derived: sum of 3 quarters · filed 2023-02-23 | $33.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $6.00M derived: sum of 2 quarters · filed 2023-02-23 | $5.00M derived: sum of 3 quarters · filed 2023-02-23 | $24.00M 10-K · filed 2023-02-23 | |||
| 2020-09-27 | -$2.00M 10-Q · filed 2021-11-12 | -$3.00M derived: sum of 2 quarters · filed 2021-11-12 | $16.00M 10-Q · filed 2021-11-12 | $28.00M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-28 | -$1.00M 10-Q · filed 2021-08-12 | $18.00M 10-Q · filed 2021-08-12 | $30.00M derived: sum of 3 quarters · filed 2022-02-24 | $33.00M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-29 | $19.00M 10-Q · filed 2021-05-13 | $31.00M derived: sum of 2 quarters · filed 2022-02-24 | $34.00M derived: sum of 3 quarters · filed 2022-02-24 | $40.00M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $15.00M derived: sum of 2 quarters · filed 2022-02-24 | $21.00M derived: sum of 3 quarters · filed 2022-02-24 | $25.00M 10-K · filed 2022-02-24 | |||
| 2019-09-29 | $3.00M 10-Q · filed 2020-11-05 | $9.00M derived: sum of 2 quarters · filed 2020-11-05 | $13.00M 10-Q · filed 2020-11-05 | $18.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $6.00M 10-Q · filed 2020-08-06 | $10.00M 10-Q · filed 2020-08-06 | $15.00M derived: sum of 3 quarters · filed 2021-02-25 | $73.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $5.00M 10-Q · filed 2020-05-07 | $9.00M derived: sum of 2 quarters · filed 2021-02-25 | $67.00M derived: sum of 3 quarters · filed 2021-02-25 | $94.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $62.00M derived: sum of 2 quarters · filed 2021-02-25 | $89.00M derived: sum of 3 quarters · filed 2021-02-25 | $109.00M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $58.00M 10-Q · filed 2019-11-07 | -$54.00M 10-Q · filed 2018-11-08 | $85.00M derived: sum of 2 quarters · filed 2019-11-07 | $105.00M 10-Q · filed 2019-11-07 | -$90.00M 10-Q · filed 2018-11-08 | ||
| 2018-07-01 | $27.00M 10-Q · filed 2019-08-08 | -$19.00M 10-Q · filed 2018-08-09 | $46.00M 10-Q · filed 2019-08-08 | -$31.00M 10-Q · filed 2018-08-09 | |||
| 2018-04-01 | $19.00M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |